Kendal Jensen

Kendal Jensen has an extensive background in the field of laboratory and molecular pathology. Kendal started their career as an M.D. Ph.D. at Texas A&M University from June 2008 to June 2015. Kendal then pursued a Molecular Genetic Pathology Fellowship at the University of Washington from July 2019 to July 2020.

After completing their fellowship, Kendal went on to work at several well-known organizations. From July 2020 to January 2023, they held positions at Precision Diagnostics LLC., Amprion, Sharp HealthCare, and Adaptive Biotechnologies Corp., where they served as an Associate Director, Clinical Laboratory Director, Consultant Molecular Pathologist, and Contractor Pathologist, respectively.

Most recently, Kendal joined Prometheus Laboratories Inc. as the Laboratory Director in January 2023. Their previous positions and experiences in various companies and institutions demonstrate their expertise and dedication to the field of laboratory and molecular pathology.

Kendal Jensen started their educational journey in 2015 with a Medical Residency in Pathology at UC Irvine. Following this, from 2016 to 2018, Kendal pursued further studies in Clinical Pathology at Northwell Health. In 2019, Kendal attended the University of Washington for a Fellowship in Molecular Genetic Pathology.